Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2025 ,inter alia, to consider and approve 1. To consider, approve & take ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genpharmasec Ltd has informed BSE that its Board of Directors will meet on Wednesday, 21 May 2025 at the registered office in Mumbai. The main agenda is to consider, approve and take on record the audited standalone and consolidated financial results along with the auditor's report for the quarter and full year ended 31 March 2025. Any other business may be taken up with the chairman's permission. The company has also closed its insider trading window from 1 April 2025 until 48 hours after the results are declared, as required under SEBI insider trading rules. No financial numbers, projections or specific items are disclosed in this intimation.
This is a routine pre-results announcement and does not by itself move the stock. Investors should watch the actual audited FY25 results on 21 May 2025 for performance trends, audit observations and any board-level decisions that could affect the share price.